Podcasts TV Interviews
Dec 15, 2022
The Rare Disease Diversity Coalition Webinar
October 29, 2022
Best Of Times Has Recently Been Aired On Their Radio FM Channel
November 7, 2022
Jeeva Informatics Solutions On CEO-CFO Magazine
August 16, 2022
BlueCloudTV Video Interview
BlueCloudTV Video Interview about Jeeva eClinical Cloud, its genesis, the story behind the technology, and the exciting future for faster, more diverse clinical trials.
January 15, 2022
I Don't Care PodCast
Kevin Stevenson from I Don't Care Podcast of MarketScale hosted Jeeva CEO Dr. Harsha Rajasimha in a candid conversation on the true cost of delays in clinical trials. 85% of all clinical trials are delayed by at least 30 days due to poor enrollment. What's the true cost? What are the challenges associated with global clinical research, lack of diversity, equity, and access? Rajasimha shares Jeeva's unique approach to addressing these challenges.
January 07, 2022
Purple Project PodCast
Dino Verrelli from Project Purple hosted Jeeva CEO Harsha Rajasimha, in his podcast focused on accelerating cures for pancreatic cancer. A candid conversation between two patient advocates.
November 12, 2021
Dad to Dad 175 - Dr. Harsha Rajasimha, Founder of Jeeva Informatics, Lost A Child To Edwards Syndrome
Harsha Rajasimha, Founder of Jeeva Informatics, spoke with David Hirsch, Founder of 21st Century Dads Foundation and leader of the Special Fathers Network (SFN). A candid conversation between two dads on the experience of losing a child and coping with it.
November 08, 2021
In this episode 8 of 21 in 21 series hosted by Sanjay Joshi, our CEO Harsha Rajasimha joined Kamala Maddali and Scott Schliebner for an exciting discussion on distributed clinical trials
In this episode 8 of 21 in 21 series hosted by Sanjay Joshi, our CEO Harsha Rajasimha joined Kamala Maddali and Scott Schliebner for an exciting panel discussion on decentralized clinical trials.
November 05, 2021
A Conversation Between EURweb.com (Everything Urban Radioscope) and our CEO Dr. Harsha Rajasimha on the Dire Need to Diversify Clinical Trials | VIDEO
Ricardo Hazell of @EURweb.com sat down with our CEO Dr. Harsha Rajasimha to discuss his perspectives on the Dire Need to Diversify Clinical Trials. “There are clinical research projects or clinical trials which can help patients living with chronic or rare diseases anywhere in the world. But 80 percent of all clinical trial participants continue to be Caucasian, most of them male and middle-aged from an affluent background.” How can digital health and SaaS technology help address this challenge?
November 03, 2021
In this episode of Life Science Success, Donald L. Davis spoke with Harsha Rajasimha, CEO of Jeeva Informatics
In this episode of Life Science Success, we are speaking with Harsha Rajasimha. Harsha is a Social Entrepreneur committed to applying his 15+ years of distinguished experience in healthcare and life sciences consulting, precision medicine, genomics of rare diseases, and cancer to help accelerate drug R&D and digital therapeutics.
October 27, 2021
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Harsha K. Rajasimha, PhD, in Herndon, Virginia.
Dr. Harsha Rajasimha, CEO of Jeeva Informatics, has also founded a couple of non-profit organizations focused on improving the diversity, equity, and inclusion (DE&I) of patients in clinical trials worldwide.
September 27, 2021
"Connecting researchers & patients, East & West to accelerate therapy access" - H. Rajasimha, PhD
This lecture was given at the Defeat MSA Alliance & MSA United All-Community MSA Conference (Sept 24-Oct 2, 2021)
September 20, 2021
Disruption Interruption Podcast by Karla Jo Helms of JOTOPR: Clinical Trials by Innovator Dr. Harsha Rajasimha of Jeeva
Disruption Interruption podcast host and veteran communications disruptor, Karla Jo Helms of JoTo PR Disruptors, interviewed Dr. Harsha Rajasimha, Founder & CEO of Jeeva Informatics Solutions Inc.—and uncovered how he has utilized his experiences and education to bring disruption into the pharmaceutical and healthcare industry by listening to all stakeholders involved in the process of clinical trials.
September 15, 2021
Newswatch 16 WNEP-TV: Calling for more diversity in clinical trials
Medical experts say this health crisis has made it all the more clear how important diversity is in clinical trials. “The effect is significant in terms of science, medicine, and also the population that we are all trying to serve," said Dr. Harsha Rajasimha, founder and CEO of Jeeva Informatics Solutions Inc.
August 30, 2021
Management Blueprint Podcast with Steve Preda: Building a world-class company that helps researchers accelerate clinical studies
Pinnacle Business Guide's Steve Preda interviewed our founder and CEO Dr. Harsha Rajasimha about his journey building and scaling a Software as a Service (SaaS) business that helps patients, clinical researchers, biopharma sponsors, and non-profit research organizations.
July 17, 2021
2021 NDF Speaker Series: Dr. Harsha Rajasimha, CEO and Founder of Jeeva Informatics Solutions, Inc. discusses patient databases.
Neuromuscular Disease Foundation (NDF) mission is to enhance the quality of the lives of people living with GNE Myopathy through advocacy, education, outreach, and funding critical research focused on treatments and a cure.
February 27, 2021
Discussion on Open data for Rare diseases: An Indian Perspective
The Department of Science and Technology (DST) center for policy research at the Indian Institute of Science (IISc) hosted a panel discussion during Rare Disease Week 2021 on Open data for Rare diseases: An Indian Perspective Panelists: Prof. Vijay Chandru, Faculty at the Centre for BioSystems Science and Engineering at IISc. Prof. Arkalgud Ramaprasad, Director of the Ramaiah Public Policy Center, Bengaluru, India. Dr. Harsha Rajasimha, Founder and CEO, Jeeva Informatics Solutions Inc., Tysons Corner, VA, USA Dr. Shilpi Bhattacharya, Professor of Law at Jindal Global Law School, O.P. Jindal Global University, India
November 18, 2020
MissionMatters Podcast with Adam Torres: Decentralizing Clinical Research for Rare Diseases at Scale
Decentralizing clinical research can have many benefits such as cutting costs. In this episode, Adam Torres and Harsha K. Rajasimha, Founder and CEO of Jeeva Informatics and Founder and Chairman of Indo US Organization for Rare Diseases, explore the benefits and process of decentralizing clinical research.
Source: MISSION MATTERS
Listen to the podcast
July 7, 2020
Podbean Podcast: Wait How do you spell that rare disease? Decentralizing Clinical Trials with Harsha Rajasimha from Jeeva Informatics Solutions
In this interview from Rare Disease Day at the NIH, Ilana Bean talks to Dr. Harsha Rajasimha, the CEO and founder of Jeeva Informatics Solutions about how clinical trials can change to better meet rare patient needs-- in the US, India, and across the world.
Source: Wait How Do You Spell That?
Listen to the podcast
February 12, 2020
RareCast By Global Genes with Daniel Levine: Bringing Clinical Trials to Patients
Conducting rare disease clinical trials can be challenging because of small and geographically dispersed groups of patients who may face difficulties in traveling to trial sites. Regulatory requirements for cell and gene therapies, even if only administered once, require long-term follow-ups that extend for many years and provide an ongoing burden for patients. Jeeva Informatics Solutions is seeking to address those challenges through it harnessing of digital health technologies to bring the trial to the patient. We spoke to Harsha Rajasimha, founder and CEO of Jeeva, about the challenges of conducting rare disease clinical trials, the potential of digital health technologies to address those issues, and how ready regulators and sponsors may be to embrace these technologies to transform the way they conduct clinical trials today.
Source: RARECast by Global Genes
Listen to the podcast